---
title: "300702.SZ (300702.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300702.SZ/news.md"
symbol: "300702.SZ"
name: "300702.SZ"
parent: "https://longbridge.com/en/quote/300702.SZ.md"
datetime: "2026-05-20T08:14:08.460Z"
locales:
  - [en](https://longbridge.com/en/quote/300702.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300702.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300702.SZ/news.md)
---

# 300702.SZ (300702.SZ) — Related News

### [TIANYU PHARM: The drug registration certificate for Canagliflozin tablets has been obtained](https://longbridge.com/en/news/286880835.md)
*2026-05-19T08:50:03.000Z*
> TIANYU PHARM's wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical, recently obtained the drug registration certifica

### [TIANYU PHARM: Plans to change part of the use of raised funds to invest in the "Synthetic Acetonitrile Project"](https://longbridge.com/en/news/286566303.md)
*2026-05-15T12:35:06.000Z*
> TIANYU PHARM announced that the company will hold a board meeting on May 15, 2026, to review and approve the proposal to

### [Intraday News - TIANYU PHARM (8171) stock price hits the limit up, limit up price is 24.0 yuan, with a transaction of 466 lots](https://longbridge.com/en/news/285663290.md)
*2026-05-08T04:27:41.000Z*
> TIANYU (8171-TW) stock price rose by 2.15 TWD at 12:27 on the 8th, reaching the limit-up price of 24.0 TWD, with a tradi

### [TIANYU PHARM: Net profit in the first quarter was 42.1915 million yuan, a year-on-year decrease of 51.04%](https://longbridge.com/en/news/283838932.md)
*2026-04-23T13:05:45.000Z*
> TIANYU PHARM announced that its revenue for the first quarter of 2026 was 812 million yuan, a year-on-year increase of 6

### [TIANYU PHARM plans to acquire over 87% of Shanghai Xingke's shares to optimize its industrial chain layout](https://longbridge.com/en/news/281030645.md)
*2026-03-30T13:31:46.000Z*
> On the evening of March 30th, TIANYU PHARM (300702) announced that the company intends to acquire 87.8173% of the shares

### [TIANYU PHARM: Plans to acquire 87.8173% equity of Shanghai Xingke for 334 million yuan](https://longbridge.com/en/news/281009005.md)
*2026-03-30T11:25:10.000Z*
> Sina Finance reported on March 30th that TIANYU PHARM announced that the company intends to pay cash of 334 million yuan

### [TIANYU PHARM: Chief Financial Officer Wang Xiujuan resigned for personal reasons](https://longbridge.com/en/news/275870885.md)
*2026-02-13T08:36:22.000Z*
> On February 13th, TIANYU PHARM announced that the company's board of directors recently received the resignation letter 

### [Zhongtai Securities: Strategically optimistic about the raw material pharmaceutical sector](https://longbridge.com/en/news/274886024.md)
*2026-02-04T23:53:05.000Z*
> Zhongtai Securities research report indicates a strategic optimism for the raw material drug sector: innovative drug hot

### [Market Update - TIANYU PHARM (8171) surged 7.05%, reported at 31.9 yuan](https://longbridge.com/en/news/273446506.md)
*2026-01-23T01:17:47.000Z*
> TIANYU (8171-TW) stock price rose by 2.1 TWD at 09:17 on the 23rd, reporting at 31.9 TWD, an increase of 7.05%, with a t